- Home
- FIBK vs CRNX Comparison
FIBK vs CRNX Comparison
Compare FIBK & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIBK
- CRNX
- Stock Information
- Founded
- FIBK 1879
- CRNX 2008
- Country
- FIBK United States
- CRNX United States
- Employees
- FIBK N/A
- CRNX N/A
- Industry
- FIBK Major Banks
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- FIBK Finance
- CRNX Health Care
- Exchange
- FIBK Nasdaq
- CRNX Nasdaq
- Market Cap
- FIBK 2.6B
- CRNX 2.8B
- IPO Year
- FIBK 2010
- CRNX 2018
- Fundamental
- Price
- FIBK $32.68
- CRNX $34.00
- Analyst Decision
- FIBK Buy
- CRNX Strong Buy
- Analyst Count
- FIBK 7
- CRNX 7
- Target Price
- FIBK $34.57
- CRNX $74.33
- AVG Volume (30 Days)
- FIBK 759.2K
- CRNX 1.1M
- Earning Date
- FIBK 10-23-2025
- CRNX 11-11-2025
- Dividend Yield
- FIBK 5.72%
- CRNX N/A
- EPS Growth
- FIBK N/A
- CRNX N/A
- EPS
- FIBK 2.22
- CRNX N/A
- Revenue
- FIBK $935,300,000.00
- CRNX $1,392,000.00
- Revenue This Year
- FIBK $10.42
- CRNX $489.51
- Revenue Next Year
- FIBK $3.69
- CRNX $661.93
- P/E Ratio
- FIBK $14.81
- CRNX N/A
- Revenue Growth
- FIBK N/A
- CRNX 0.51
- 52 Week Low
- FIBK $22.95
- CRNX $24.10
- 52 Week High
- FIBK $36.77
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- FIBK 62.03
- CRNX 57.57
- Support Level
- FIBK $32.00
- CRNX $33.19
- Resistance Level
- FIBK $32.99
- CRNX $37.23
- Average True Range (ATR)
- FIBK 0.58
- CRNX 1.49
- MACD
- FIBK -0.02
- CRNX 0.23
- Stochastic Oscillator
- FIBK 64.60
- CRNX 55.87
About FIBK First Interstate BancSystem Inc. (DE)
First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism, and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.